一 、A strong technical team

     Company existing staff of 12, the rich people to recognize more than 60% of our general manager and technical director engaged in tumor formation mechanism of molecular biology and translational medicine research Dr. Xue is established at first international leading, can be widely used in many kinds of cancer mechanism to guide the design of research and development of antineoplastic drugs development series of tumor resistance gene mutation detection reagent clinical work provides important technical means such as individualized treatment the research achievements of xue bo in famous journals such as Nature more high level paper Dr. Stephan W. Morris, md, consultant to our company's science and technology experts.      Dr. Morris is a leading expert and scholar in the field of cancer research. He is the discoverer of the ALK gene and holds several patents related to the ALK gene. Morris's laboratory, in collaboration with Vysis (now Abbott), designed and developed a fluorescence in situ hybridization probe to detect ALK break rearrangement, It has been approved by the FDA to detect the abnormal function of ALK gene in lung cancer and the concomitant diagnosis of cloxotinib, a new anti-cancer drug of Pfizer. Dr. Morris has been supported by several NIH and other research funds, He has published several academic papers in leading scientific journals such as Science, Nature Genetics, Nature Immunology and Cell. He is a reviewer, editorial board, NIH Foundation Reviewer, and a scientific consultant to many biopharmaceutical companies in the U.S.A., and is also a reviewer of several leading scientific journals.

     Dr. Morris is a co-founder of Insight Genetics and HealthChartLLC LLC., USA, He is a scientific consultant of Shaoxing Jin Luan Biotechnology Co., Ltd., participating in the guidance of the company's product development strategy, and chairing the academic research and exchange activities with clinical research institutions and pharmaceutical companies at home and abroad.In recent years, Dr. Xue has also established HealthChart LLC with Dr. Morris, a famous American scholar. He is mainly engaged in the research and development of clinical diagnostic test products for oncogene, clinical research and testing, and technical services. The company has established partnerships with Pfizer, Qiagen and InsightGenetics of the United States, and has started project business cooperation.


二 、Product advantage

     We established a platform for the preparation, labeling and gene detection of fluorescent in situ hybridization ( FISH) probes without repeating sequences. Compared with the traditional fluorescence in situ hybridization ( FISH), this technique has the advantages of strong signal, small background, high sensitivity and good repeatability, etc. The in situ hybridization probe without repeating sequence can be rapidly prepared, the operation is simple, the detection procedure is simplified, the detection time is greatly shortened, the detection cost is low, and it is easy to realize industrialization.

OUR ADVANTAGE

OUR ADVANTAGE

副标题

地址:绍兴袍江群贤路与中兴大道东南角三楼310室